Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Novavax Inc NVAX

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire 1 day ago

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire 8 days ago

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire 10 days ago

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire April 11, 2024

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire April 9, 2024

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire April 4, 2024

Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement

Accesswire April 2, 2024

Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024

PR Newswire April 1, 2024

Novavax to Participate in TD Cowen's 44th Annual Health Care Conference

PR Newswire February 29, 2024

Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

PR Newswire February 28, 2024

Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement

PR Newswire February 22, 2024

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024

PR Newswire February 20, 2024

Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire January 3, 2024

Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan

PR Newswire December 18, 2023

Canadians Can Help Protect Loved Ones as We Head into the Holiday Season

Canada NewsWire December 13, 2023

Novavax's Updated COVID-19 Vaccine Now Authorized in Canada

PR Newswire December 5, 2023

Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization

PR Newswire November 28, 2023

Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities

PR Newswire November 17, 2023

Novavax to Participate in Jefferies London Healthcare Conference

PR Newswire November 10, 2023

Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights

PR Newswire November 9, 2023